{"id":20965,"date":"2022-05-30T18:33:41","date_gmt":"2022-05-30T18:33:41","guid":{"rendered":"https:\/\/www.africa-press.net\/ghana\/uncategorized\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls"},"modified":"2022-05-30T18:50:58","modified_gmt":"2022-05-30T18:50:58","slug":"china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls","title":{"rendered":"China grants approval for GSK\u2019s two-dose HPV vaccine for girls"},"content":{"rendered":"

Africa-Press – Ghana. <\/strong><\/span>In a study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% decline in cervical cancer incidences. China\u2019s National Medical Products Administration (NMPA) has granted approval for GlaxoSmithKline\u2019s (GSK) two-dose vaccine schedule, Cervarix, in girls between the age of nine to 14 years to prevent cervical cancer.<\/p>\n

It is also indicated for preventing cervical intraepithelial neoplasia and adenocarcinoma in situ, linked to oncogenic human papillomavirus (HPV) types 16 and 18.<\/p>\n

Cervarix is a recombinant, non-infectious, AS04-adjuvanted HPV bivalent (types 16, 18) vaccine.<\/p>\n

With the latest approval, Cervarix became the first two-dose HPV vaccine imported for individuals of this age group in mainland China.<\/p>\n

Apart from China, the two-dose vaccine regimen of Cervarix is approved in nearly 100 countries, including Asia, Africa, the European Union, and Latin America.<\/p>\n

For girls and women aged 15 to 45 years, the three-dose vaccine regimen remains on the label in China.<\/p>\n

The company noted that the vaccine showed direct evidence of reducing cervical cancer occurrence rates.<\/p>\n

According to data from a register-based study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% and 97% decline in cervical cancer and precancerous lesions such as cervical intraepithelial neoplasia (CIN) grade 3, respectively.<\/p>\n

These findings signify a more substantial effect than anticipated based on the occurrence of the HPV 16\/18 strains included in the vaccine.<\/p>\n

The vaccine was found to be 93\u00b72% effective against all CIN3+, regardless of HPV type in the lesion and including lesions with no HPV 16\/18 DNA spotted, indicating a benefit broader than HPV 16\/18.<\/p>\n

Among all malignant tumours in the female reproductive system in China, cervical cancer has an increased mortality rate.<\/p>\n

In April this year, the company entered an agreement to acquire Sierra Oncology for $1.9bn in cash.<\/p>\n

For More News And Analysis About Ghana<\/a> Follow Africa-Press<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Africa-Press – Ghana. In a study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% decline in cervical cancer incidences. China\u2019s National Medical Products Administration (NMPA) has granted approval for GlaxoSmithKline\u2019s (GSK) two-dose vaccine schedule, Cervarix, in girls between the age of nine to 14 years to prevent […]<\/p>\n","protected":false},"author":84,"featured_media":20964,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,8,9],"tags":[5092,5096,5260,429,8964],"class_list":["post-20965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-news","category-homepage-english","category-miscellaneous","tag-africa-press","tag-africa-press-ghana","tag-china","tag-ghana","tag-hpv-vaccine"],"yoast_head":"\nChina grants approval for GSK\u2019s two-dose HPV vaccine for girls - Ghana<\/title>\n<meta name=\"description\" content=\"In a study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% decline in cervical cancer in ...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China grants approval for GSK\u2019s two-dose HPV vaccine for girls\" \/>\n<meta property=\"og:description\" content=\"In a study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% decline in cervical cancer in ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls\" \/>\n<meta property=\"og:site_name\" content=\"Ghana\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AfricaPressTunisiaa\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-30T18:33:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-30T18:50:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"731\" \/>\n\t<meta property=\"og:image:height\" content=\"485\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cfeditoren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditoren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls\"},\"author\":{\"name\":\"cfeditoren\",\"@id\":\"https:\/\/www.africa-press.net\/ghana\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\"},\"headline\":\"China grants approval for GSK\u2019s two-dose HPV vaccine for girls\",\"datePublished\":\"2022-05-30T18:33:41+00:00\",\"dateModified\":\"2022-05-30T18:50:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls\"},\"wordCount\":306,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg\",\"keywords\":[\"Africa Press\",\"Africa Press-Ghana\",\"China\",\"ghana\",\"HPV vaccine\"],\"articleSection\":[\"all news\",\"homepage-english\",\"miscellaneous\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls\",\"url\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls\",\"name\":\"China grants approval for GSK\u2019s two-dose HPV vaccine for girls - Ghana\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/ghana\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg\",\"datePublished\":\"2022-05-30T18:33:41+00:00\",\"dateModified\":\"2022-05-30T18:50:58+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/ghana\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\"},\"description\":\"In a study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% decline in cervical cancer in ...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg\",\"width\":731,\"height\":485,\"caption\":\"China grants approval for GSK\u2019s two-dose HPV vaccine for girls\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.africa-press.net\/ghana\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China grants approval for GSK\u2019s two-dose HPV vaccine for girls\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/ghana\/#website\",\"url\":\"https:\/\/www.africa-press.net\/ghana\/\",\"name\":\"Ghana\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/ghana\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/ghana\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\",\"name\":\"cfeditoren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.africa-press.net\/ghana\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7417380fa9e23b5c57fdbfdaf3fdf92ee478f759a084addda5faa3732853e74a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7417380fa9e23b5c57fdbfdaf3fdf92ee478f759a084addda5faa3732853e74a?s=96&d=mm&r=g\",\"caption\":\"cfeditoren\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China grants approval for GSK\u2019s two-dose HPV vaccine for girls - Ghana","description":"In a study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% decline in cervical cancer in ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls","og_locale":"en_US","og_type":"article","og_title":"China grants approval for GSK\u2019s two-dose HPV vaccine for girls","og_description":"In a study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% decline in cervical cancer in ...","og_url":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls","og_site_name":"Ghana","article_publisher":"https:\/\/www.facebook.com\/AfricaPressTunisiaa","article_published_time":"2022-05-30T18:33:41+00:00","article_modified_time":"2022-05-30T18:50:58+00:00","og_image":[{"width":731,"height":485,"url":"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg","type":"image\/jpeg"}],"author":"cfeditoren","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cfeditoren","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls"},"author":{"name":"cfeditoren","@id":"https:\/\/www.africa-press.net\/ghana\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb"},"headline":"China grants approval for GSK\u2019s two-dose HPV vaccine for girls","datePublished":"2022-05-30T18:33:41+00:00","dateModified":"2022-05-30T18:50:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls"},"wordCount":306,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg","keywords":["Africa Press","Africa Press-Ghana","China","ghana","HPV vaccine"],"articleSection":["all news","homepage-english","miscellaneous"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls","url":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls","name":"China grants approval for GSK\u2019s two-dose HPV vaccine for girls - Ghana","isPartOf":{"@id":"https:\/\/www.africa-press.net\/ghana\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg","datePublished":"2022-05-30T18:33:41+00:00","dateModified":"2022-05-30T18:50:58+00:00","author":{"@id":"https:\/\/www.africa-press.net\/ghana\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb"},"description":"In a study in England, girls aged 12 to 13 years who received the vaccine doses had an 87% decline in cervical cancer in ...","breadcrumb":{"@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#primaryimage","url":"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg","contentUrl":"https:\/\/static.africa-press.net\/ghana\/sites\/18\/2022\/05\/img-629511f6a3acd.jpg","width":731,"height":485,"caption":"China grants approval for GSK\u2019s two-dose HPV vaccine for girls"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/ghana\/all-news\/china-grants-approval-for-gsks-two-dose-hpv-vaccine-for-girls#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.africa-press.net\/ghana\/"},{"@type":"ListItem","position":2,"name":"China grants approval for GSK\u2019s two-dose HPV vaccine for girls"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/ghana\/#website","url":"https:\/\/www.africa-press.net\/ghana\/","name":"Ghana","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/ghana\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/ghana\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb","name":"cfeditoren","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.africa-press.net\/ghana\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7417380fa9e23b5c57fdbfdaf3fdf92ee478f759a084addda5faa3732853e74a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7417380fa9e23b5c57fdbfdaf3fdf92ee478f759a084addda5faa3732853e74a?s=96&d=mm&r=g","caption":"cfeditoren"}}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/posts\/20965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/users\/84"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/comments?post=20965"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/posts\/20965\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/media\/20964"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/media?parent=20965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/categories?post=20965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/ghana\/wp-json\/wp\/v2\/tags?post=20965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}